News

The largest domestic pharmaceutical company, Bosnalijek j.s.c., in the first nine months of 2022, achieved total revenue of 120.5 million BAM and thereby achieved revenue growth of 33.4 million BAM or 38 percent compared to the same period last year.

In the first half of 2022, Bosnalijek, the largest pharmaceutical company in Bosnia and Herzegovina, made record profit before tax of BAM 20.7 million, an increase by BAM 18.9 million compared to the same period of the previous year. The profit is the result of the successfully implemented strategy and activities of the management and employees of Bosnalijek.